Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

224
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
224
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

186
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
186
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

297
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
297
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

292
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
292
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

406
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
406
Chronopharmacokinetics: Time-Dependent Pharmacokinetics01:20

Chronopharmacokinetics: Time-Dependent Pharmacokinetics

172
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
172

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arterial Blood-Mediated Deep-Tissue Photoacoustic Oximetry.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Engineered multivalent VCAM1-Fc decoys remodel ECM mechanosensing to suppress H3K18la-driven epigenetic programs and stemness in recurrent glioblastoma.

Cancer letters·2026
Same author

A dominant-negative tyrosine kinase 2 mutation abolishes interleukin-23 signalling and drives severe adult kerion caused by Trichophyton violaceum.

The British journal of dermatology·2026
Same author

Integrated evaluation of antibody responses to mosquitoes and mosquito-borne pathogens using highly multiplexed serology.

Science advances·2026
Same author

Selective Inhibition of Glioma Cells In Vivo via Low Intensity Ultrasound.

Ultrasound in medicine & biology·2026
Same author

Strain diversity drives heterogeneous responses to tuberculosis combination therapy.

Antimicrobial agents and chemotherapy·2026

Related Experiment Video

Updated: Aug 11, 2025

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.9K

Spatiotemporal perspectives on tuberculosis chemotherapy.

Junhao Zhu1, Yue J Liu1, Sarah M Fortune2

  • 1Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, USA.

Current Opinion in Microbiology
|February 6, 2023
PubMed
Summary
This summary is machine-generated.

Understanding the interplay between Mycobacterium tuberculosis (Mtb) and the immune system over time and space is crucial for effective tuberculosis (TB) treatment. This review explores how spatiotemporal dynamics influence Mtb survival and treatment outcomes.

More Related Videos

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.9K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K

Related Experiment Videos

Last Updated: Aug 11, 2025

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.9K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.9K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K

Area of Science:

  • Immunology
  • Microbiology
  • Pharmacology

Background:

  • Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), leads to millions of infections and deaths annually.
  • Mtb and host immune responses create complex, dynamic microenvironments during infection.
  • Current understanding of TB's temporal dynamics, especially during drug treatment, is limited compared to its spatial complexity.

Purpose of the Study:

  • To review emerging data on the spatiotemporal dynamics of TB disease and treatment.
  • To highlight the role of combined spatial and temporal heterogeneity in Mtb survival during treatment.
  • To identify potential opportunities for novel TB treatment regimens based on a deeper understanding of these dynamics.

Main Methods:

  • Literature review of studies investigating the spatial and temporal aspects of TB.
  • Analysis of host-pathogen-antibiotic interactions within varying microenvironments.
  • Synthesis of data on how spatiotemporal factors influence Mtb survival and treatment efficacy.

Main Results:

  • Spatiotemporal heterogeneity creates niches and time windows for Mtb survival during therapy.
  • The dynamic interplay between Mtb, host immunity, and antibiotics is critical for treatment outcomes.
  • Understanding these complex interactions is essential for deciphering treatment failure.

Conclusions:

  • A comprehensive understanding of Mtb's spatiotemporal dynamics is vital for improving TB treatment strategies.
  • Elucidating these interactions can help overcome treatment failures and inform the development of new therapeutic approaches.
  • Future research should focus on integrating spatial and temporal data to better combat tuberculosis.